Cargando…
Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550194/ https://www.ncbi.nlm.nih.gov/pubmed/32935133 http://dx.doi.org/10.1093/eurheartj/ehaa731 |
| _version_ | 1783592924872704000 |
|---|---|
| author | Butler, Javed Zannad, Faiez Filippatos, Gerasimos Anker, Stefan D. Packer, Milton |
| author_facet | Butler, Javed Zannad, Faiez Filippatos, Gerasimos Anker, Stefan D. Packer, Milton |
| author_sort | Butler, Javed |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7550194 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75501942020-10-16 Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice Butler, Javed Zannad, Faiez Filippatos, Gerasimos Anker, Stefan D. Packer, Milton Eur Heart J Viewpoint Oxford University Press 2020-09-15 /pmc/articles/PMC7550194/ /pubmed/32935133 http://dx.doi.org/10.1093/eurheartj/ehaa731 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Viewpoint Butler, Javed Zannad, Faiez Filippatos, Gerasimos Anker, Stefan D. Packer, Milton Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice |
| title | Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice |
| title_full | Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice |
| title_fullStr | Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice |
| title_full_unstemmed | Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice |
| title_short | Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice |
| title_sort | totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice |
| topic | Viewpoint |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550194/ https://www.ncbi.nlm.nih.gov/pubmed/32935133 http://dx.doi.org/10.1093/eurheartj/ehaa731 |
| work_keys_str_mv | AT butlerjaved totalityofevidenceintrialsofsodiumglucosecotransporter2inhibitorsinthepatientswithheartfailurewithreducedejectionfractionimplicationsforclinicalpractice AT zannadfaiez totalityofevidenceintrialsofsodiumglucosecotransporter2inhibitorsinthepatientswithheartfailurewithreducedejectionfractionimplicationsforclinicalpractice AT filippatosgerasimos totalityofevidenceintrialsofsodiumglucosecotransporter2inhibitorsinthepatientswithheartfailurewithreducedejectionfractionimplicationsforclinicalpractice AT ankerstefand totalityofevidenceintrialsofsodiumglucosecotransporter2inhibitorsinthepatientswithheartfailurewithreducedejectionfractionimplicationsforclinicalpractice AT packermilton totalityofevidenceintrialsofsodiumglucosecotransporter2inhibitorsinthepatientswithheartfailurewithreducedejectionfractionimplicationsforclinicalpractice |